Skip to content

Electromyographic Evaluation of Quadriceps During Eccentric Decline Squat

Electromyographic Evaluation of Quadriceps During Eccentric Decline Squat: An Investigation of the Effect of Decline Angle and Arc of Motion

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04204460
Enrollment
20
Registered
2019-12-19
Start date
2019-12-15
Completion date
2019-12-22
Last updated
2019-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patellar Tendinopathy

Keywords

eccentric squatting, electromyografic activation, exercise, patellar tendinopathy

Brief summary

Previous studies have generally investigated patellar tendon stiffness, cross-sectional area of patellar tendon, patellar tendon length, patellar force and patellafemoral forces during decline squat. However, there is just a few study about electromyographic (EMG) activity during the eccentric squating, which is about rectus femoris (RF) recruitment. In the present study the investigators primarly aimed to quantify the activation of RF, vastus lateralis (VL), and vastus medialis obliqus (VMO) during eccentric squat on different decline angle (0, 5°, 10°, 15°, 20°). An additional purpose of our study was to compare the changes in muscle activation at various arc of knee flexion motion (degrees of 0-30, 30-60, 60-90, 0-60, 30-90, 0-90).The investigators hypothesised that the recruitment of RF, VL, and VMO during eccentric squat would differ according to decline angle and arc of motion.

Detailed description

The squat procedure in each condition will be repeated 10 times on a treadmill. The treadmill will be used to adjust the degree of decline in a standard manner. There will be a metronome to keep the speed of exercise in the same rhythm. All squats will be performed with a weighted barbell. The weight of it will be set as in ratio 30% of the participant's body weight

Interventions

None listed

Sponsors

Ordu University
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* had exercised regularly (\>3 days in a week) for at least six months. * older than 18 years old.

Exclusion criteria

* had patellofemoral pain, knee pain otherwise unrelated to the knee extensor mechanism and other injuries that would restrict performance of the tasks (e.g. ankle pathology).

Design outcomes

Primary

MeasureTime frameDescription
Electromyographic measurement of muscle activation50 minutesSurface electromyographic (EMG) system (Noraxon Telemyo DTS System, Scottsdale, USA) will be use to measure the muscle activation ratios of RF, VL, and VMO. Electrodes will be placed according to Surface EMG for noninvasive assessment of muscles (SENIAM) recommendations on the dominant leg. The muscle activation during eccentric phase of the decline squat for RF, VL, and VMO will be determined. The decline squat will be performed under different conditions (various decline angle: 0, 5, 10,15, 20 degree) The muscle activation will also be investigated within various arc of motion of knee flexion (0-30, 30-60, 60-90, 0-60, 0-90, 30-90) which is determined using the motion analysis system (Noraxon, MYOmotion Scottsdale, USA).
Maximal voluntary isometric contractions (MVICs)5 minutesMVICs for the RF, VL, and VMO at their manual muscle test positions will be assessed within 3 trials, which lasts 5 seconds. The muscle test position will be standardized 90 degrees hip flexion and 60 degrees knee flexion. One minute a rest period will be between each trial. The peak EMG amplitude will be used for the normalization.
Normalized EMG values5 minutesThe amount of muscle activation in each condition will be proportioned to MVICs value for normalization using a calculator. The value will be represented in percentile (%).

Secondary

MeasureTime frameDescription
Weight1 minuteThe participant's weight will be determined a weighing machine inkilogram.
Height1 minuteThe participant's height will be measured in cm.

Countries

Turkey (Türkiye)

Contacts

Primary ContactSevim Acaröz Candan, PhD
fzt_acaroz@hotmail.com004522265200

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026